Compugen (CGEN) Equity Income (2023 - 2025)

Compugen (CGEN) reported Equity Income of $56.8 million for Q4 2025, up 1029.3% on a YoY basis from $5.0 million in Q4 2024, and up 914.51% sequentially from -$7.0 million in Q3 2025.

Compugen (CGEN) Equity Income (2023 - 2025) Analysis & Trends

Compugen (CGEN) has 3 years of Equity Income data on file, last reported at $56.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Equity Income rose 1029.3% year-over-year to $56.8 million; the trailing twelve-month figure through Dec 2025 stood at $45.0 million (up 1004.12% YoY), and the FY2025 full-year result was $35.3 million, up 348.35% from the prior year.
  • Equity Income rose to $56.8 million in Q4 2025, from -$7.0 million in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $56.8 million in Q4 2025 to a low of -$9.9 million in Q3 2023.
  • A 3-year average of $7.5 million and a median of -$2.4 million in 2024 frame the typical range for Equity Income.
  • Peak annual rise in Equity Income reached 1029.3% in 2025, while the deepest fall reached 646.94% in 2025.
  • Tracing CGEN's Equity Income over 3 years: stood at $9.7 million in 2023, then sank by 162.98% to -$6.1 million in 2024, then jumped by 1029.3% to $56.8 million in 2025.
  • Business Quant data shows CGEN's Equity Income at $56.8 million in Q4 2025, -$7.0 million in Q3 2025, and -$6.1 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Compugen 215.59 Mn 123.84 Mn 352,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2025 56.85 Mn
Sep 30, 2025 -6.98 Mn
Dec 31, 2024 -6.12 Mn
Sep 30, 2024 1.28 Mn
Dec 31, 2023 9.71 Mn
Sep 30, 2023 -9.85 Mn